Release Date: 19/06/12 14:44 Summary: Despatch of BuyBack Documents Price Sensitive: No Download Document 2.58MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%